188 related articles for article (PubMed ID: 29732995)
1. Vitamin Producing Lactic Acid Bacteria as Complementary Treatments for Intestinal Inflammation.
de Moreno de LeBlanc A; Levit R; de Giori GS; LeBlanc JG
Antiinflamm Antiallergy Agents Med Chem; 2018; 17(1):50-56. PubMed ID: 29732995
[TBL] [Abstract][Full Text] [Related]
2. Application of vitamin-producing lactic acid bacteria to treat intestinal inflammatory diseases.
LeBlanc JG; Levit R; Savoy de Giori G; de Moreno de LeBlanc A
Appl Microbiol Biotechnol; 2020 Apr; 104(8):3331-3337. PubMed ID: 32112134
[TBL] [Abstract][Full Text] [Related]
3. Recent update on lactic acid bacteria producing riboflavin and folates: application for food fortification and treatment of intestinal inflammation.
Levit R; Savoy de Giori G; de Moreno de LeBlanc A; LeBlanc JG
J Appl Microbiol; 2021 May; 130(5):1412-1424. PubMed ID: 32955761
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of a mixture of vitamin-producing and immune-modulating lactic acid bacteria as adjuvant for therapy in a recurrent mouse colitis model.
Levit R; Savoy de Giori G; de Moreno de LeBlanc A; LeBlanc JG
Appl Microbiol Biotechnol; 2019 Nov; 103(21-22):8937-8945. PubMed ID: 31520133
[TBL] [Abstract][Full Text] [Related]
5. Role of Lactic Acid Probiotic Bacteria in IBD.
Vemuri R; Gundamaraju R; Eri R
Curr Pharm Des; 2017; 23(16):2352-2355. PubMed ID: 28176664
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effect of soymilk fermented by a riboflavin-producing Lactobacillus plantarum strain in a murine model of colitis.
Levit R; de Giori GS; de Moreno de LeBlanc A; LeBlanc JG
Benef Microbes; 2017 Feb; 8(1):65-72. PubMed ID: 27873546
[TBL] [Abstract][Full Text] [Related]
7. Folate-producing lactic acid bacteria reduce inflammation in mice with induced intestinal mucositis.
Levit R; Savoy de Giori G; de Moreno de LeBlanc A; LeBlanc JG
J Appl Microbiol; 2018 Nov; 125(5):1494-1501. PubMed ID: 29969527
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of vitamin-producing and immunomodulatory lactic acid bacteria as a potential co-adjuvant for cancer therapy in a mouse model.
Levit R; Savoy de Giori G; de Moreno de LeBlanc A; LeBlanc JG
J Appl Microbiol; 2021 Jun; 130(6):2063-2074. PubMed ID: 33128836
[TBL] [Abstract][Full Text] [Related]
9. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials.
Saez-Lara MJ; Gomez-Llorente C; Plaza-Diaz J; Gil A
Biomed Res Int; 2015; 2015():505878. PubMed ID: 25793197
[TBL] [Abstract][Full Text] [Related]
10. Lactic Acid Bacteria Isolated From Korean Kimchi Activate the Vitamin D Receptor-autophagy Signaling Pathways.
Lu R; Shang M; Zhang YG; Jiao Y; Xia Y; Garrett S; Bakke D; Bäuerl C; Martinez GP; Kim CH; Kang SM; Sun J
Inflamm Bowel Dis; 2020 Jul; 26(8):1199-1211. PubMed ID: 32170938
[TBL] [Abstract][Full Text] [Related]
11. Probiotics: The scientific evidence in the context of inflammatory bowel disease.
Celiberto LS; Bedani R; Rossi EA; Cavallini DC
Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176
[TBL] [Abstract][Full Text] [Related]
12. Increasing the folate content of tuber based foods using potentially probiotic lactic acid bacteria.
Mosso AL; Jimenez ME; Vignolo G; LeBlanc JG; Samman NC
Food Res Int; 2018 Jul; 109():168-174. PubMed ID: 29803439
[TBL] [Abstract][Full Text] [Related]
13. Rationale for probiotic treatment strategies in inflammatory bowel disease.
Schultz M; Lindström AL
Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):337-55. PubMed ID: 19072384
[TBL] [Abstract][Full Text] [Related]
14. Probiotics and their derivatives as treatments for inflammatory bowel disease.
Prisciandaro L; Geier M; Butler R; Cummins A; Howarth G
Inflamm Bowel Dis; 2009 Dec; 15(12):1906-14. PubMed ID: 19373788
[TBL] [Abstract][Full Text] [Related]
15. Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.
Owaga E; Hsieh RH; Mugendi B; Masuku S; Shih CK; Chang JS
Int J Mol Sci; 2015 Sep; 16(9):20841-58. PubMed ID: 26340622
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
Vanderpool C; Yan F; Polk DB
Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
[TBL] [Abstract][Full Text] [Related]
17. Lactic acid bacteria producing B-group vitamins: a great potential for functional cereals products.
Capozzi V; Russo P; Dueñas MT; López P; Spano G
Appl Microbiol Biotechnol; 2012 Dec; 96(6):1383-94. PubMed ID: 23093174
[TBL] [Abstract][Full Text] [Related]
18. Bacteria as vitamin suppliers to their host: a gut microbiota perspective.
LeBlanc JG; Milani C; de Giori GS; Sesma F; van Sinderen D; Ventura M
Curr Opin Biotechnol; 2013 Apr; 24(2):160-8. PubMed ID: 22940212
[TBL] [Abstract][Full Text] [Related]
19. Effect of riboflavin-producing bacteria against chemically induced colitis in mice.
Levit R; Savoy de Giori G; de Moreno de LeBlanc A; LeBlanc JG
J Appl Microbiol; 2018 Jan; 124(1):232-240. PubMed ID: 29080295
[TBL] [Abstract][Full Text] [Related]
20. B-group vitamin production by lactic acid bacteria--current knowledge and potential applications.
LeBlanc JG; Laiño JE; del Valle MJ; Vannini V; van Sinderen D; Taranto MP; de Valdez GF; de Giori GS; Sesma F
J Appl Microbiol; 2011 Dec; 111(6):1297-309. PubMed ID: 21933312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
